Source news

tradingview News

20 stories
tradingview

Capricor Therapeutics Insiders Sold Shares Worth Over $1.5M

Krasney Karen, an officer serving as EVP, General Counsel, sold 24,100 shares of common stock under a Rule 10b5-1 trading plan at a weighted average price of $30.38 per share, with individual sale prices ranging from $30.00 to $30.88, for total proceeds of $732,158, and after the sale she directly…

TradingView en
StocksUS
tradingview

INEOS Limited Discloses Control Stake at Manchester United with 54.54% Stake

INEOS Limited, the new ultimate holding company of the INEOS group, reported beneficial ownership of 54.54% of Manchester United plc’s Class A ordinary shares. The Schedule 13D filed on June 29, 2026 reflects an internal reorganization completed on June 23, 2026. The move adds INEOS Limited as a re…

TradingView en
StocksUS
tradingview

Broadcom Chief Legal & Corp Affairs Ofc Sold Shares Worth Over $9.6M

Mark David Brazeal, an officer serving as Chief Legal & Corp Affairs Ofc, sold 25,000 shares of Broadcom common stock at $387.00 per share for a total of $9,675,000 on June 25, 2026. The transaction was a direct sale. Following the reported sale, Brazeal directly owns 244,989 shares of Broadcom com…

TradingView en
StocksUS
tradingview

Roivant Sciences President & CIO Sold Shares Worth Over $34M

Sukhatme Mayukh, an insider and President & CIO, reported sales of Common Shares on June 25 and June 26, 2026. The shares were sold at weighted average prices of $34.13 and $34.08 per share, respectively. The total proceeds from the two transactions were $34,105,000. After the reported sales, Sukha…

TradingView en
StocksUS
tradingview

Evommune, Inc. Stock 12‑Month Price Target Cut to $39.33, Implies 56% Upside

Explore more price target data and ratings for Evommune, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Evommune, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is n…

TradingView en
StocksUS
tradingview

Hormel Foods Corporation Stock 12‑Month Price Target Raised to $26.5

Explore more price target data and ratings for Hormel Foods Corporation on the Forecasts tab, and track all previous and future analyst recommendations for Hormel Foods Corporation in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. T…

TradingView en
StocksUS
tradingview

Zymeworks Inc. Stock 12‑Month Price Target Raised to $38.75, Implies 60% Upside

Explore more price target data and ratings for Zymeworks Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Zymeworks Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is n…

TradingView en
StocksUS